Author

K. Baid

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:host-pathogen & immune response· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

A. Banerjee· 3 shared A. J. McGeer· 3 shared S. Mubareka· 3 shared A. G. McArthur· 2 shared J. A. Hirota· 2 shared K. Mossman· 2 shared L. Yip· 2 shared M. A. Ostrowski· 2 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

A. Banerjee

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Immunogenicity of convalescent and vaccinated sera against clinical isolates of ancestral SARS-CoV-2, beta, delta, and omicron variants

A. Banerjee, J. Lew, A. Kroeker, K. Baid, P. Aftanas, K. Nirmalarajah, F. Maguire, R. Kozak, R. McDonald, A. Lang, V. Gerdts, S. E. Straus, L. Gilbert, A. X. Li, M. Mozafarihasjin, , D. Falzarano

The paper assesses neutralizing antibody responses of convalescent and vaccinated sera against SARS-CoV-2 ancestral, beta, delta, and omicron variants.

bioRxiv · Jan 13, 2022Immunology

Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses

A. Banerjee, N. El-Sayes, P. Budylowski, D. Richard, H. Maan, J. Aguiar, K. Baid, M. R. D'Agostino, J. C. Ang, B. J.- M. Tremblay, S. Afkhami, M. Karimzadeh, A. T. Irving, L. Yip, M. A. Ostrowski, , K. Mossman

This study shows SARS-CoV-2 infection induces a mild type I IFN response in vitro and in moderate COVID-19 cases, and cannot inhibit exogenous IFN induction.

bioRxiv · Jun 18, 2020Immunology

Isolation, sequence, infectivity and replication kinetics of SARS-CoV-2

A. Banerjee, J. A. Nasir, P. Budylowski, L. Yip, P. Aftanas, N. Christie, A. Ghalami, K. Baid, A. R. Raphenya, J. A. Hirota, M. S. Miller, A. J. McGeer, M. A. Ostrowski, R. A. Kozak, A. G. McArthur, , S. Mubareka

The paper isolates SARS-CoV-2 from two patients, sequences the virus, and tests its infectivity in human immune cells, finding that PBMCs are not permissive to infection.

bioRxiv · Apr 11, 2020 · PreprintMicrobiology